Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Director's Dealing 2014

Jul 1, 2014

5229_dirs_2014-07-01_27e057c5-cec6-472f-90ad-55180a0bdb76.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0489L

AstraZeneca PLC

01 July 2014

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 30 June 2014, Pascal Soriot, a Director of the Company, notified us that, on 30 June 2014, he purchased 46,200 AstraZeneca PLC Ordinary Shares of $0.25 each at a price of 4345 pence per share.

A C N Kemp

Company Secretary

1 July 2014

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUARKRSBABRRR